Evidence map›Paper›PMID 33921589›Full record

ArticlePharmaceuticals (Basel, Switzerland)2021

Characterization of Subtype Selective Cannabinoid CB

Yaliang Tang, Barbara Wolk, Ryan Nolan, Caitlin E Scott, Debra A Kendall

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. The CBInternational journal of molecular sciences · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Yaliang TangDepartment of Pharmaceutical Sciences, University of Connecticut, Storrs, CT 06269, USA.
Barbara WolkDepartment of Pharmaceutical Sciences, University of Connecticut, Storrs, CT 06269, USA.
Ryan NolanDepartment of Pharmaceutical Sciences, University of Connecticut, Storrs, CT 06269, USA.ORCID 0000-0002-0007-2835
Caitlin E ScottDepartment of Pharmaceutical Sciences, University of Connecticut, Storrs, CT 06269, USA.
Debra A KendallDepartment of Pharmaceutical Sciences, University of Connecticut, Storrs, CT 06269, USA.
University of Connecticut · US

Funding

NIH HHS DA5638140
6 · The paper itself

Abstract

Activation of the CB

Indexed as

agonistscannabinoid CB2 receptorcell migrationcytokinesinflammation

Identifiers

PMID33921589
PMCPMC8073686
OpenAlexW3155674898

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.